Particle.news
Download on the App Store
3 ARTICLES
·
last wk.

Pfizer Reports 85% Profit Surge, Shares Climb 12% on Strong Q4 FY25 Results

The pharmaceutical giant posted Rs 330.94 crore in net profit, announced a Rs 165 per-share dividend, and saw its stock hit a high of Rs 4,995.85.

Image
Image
Image

Overview

  • Pfizer's Q4 FY25 net profit rose 85% year-on-year to Rs 330.94 crore, driven by strong financial performance and strategic shifts in its product portfolio.
  • Revenue for the quarter increased 8% to Rs 591.91 crore compared to the same period last year, reflecting steady sales growth.
  • The board recommended a total dividend of Rs 165 per share, including special payouts marking Pfizer's 75th anniversary in India and gains from a leasehold transfer.
  • Shares surged 11.91%, reaching a high of Rs 4,995.85, with analysts noting potential resistance at Rs 5,200 and support at Rs 4,800.
  • Technical indicators show the stock is overbought, with a 14-day RSI of 83.93 and a P/E ratio of 36.86, suggesting cautious trading ahead.